Search Orphan Drug Designations and Approvals
-
Generic Name: | mecasermin, recombinant human insulin-like growth factor-1 |
---|---|
Date Designated: | 09/21/2015 |
Orphan Designation: | Treatment of Rett Syndrome. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Keck Graduate Institute of Applied Life Sciences 535 Watson Drive Claremont, California 91711 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-